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Abstract 
Next-generation sequencing technology allows investigation of both common and rare variants 
in humans. Exomes are sequenced on the population level or in families to further study the 
genetics of human diseases. Genetic Analysis Workshop 17 (GAW17) provided exomic data 
from the 1000 Genomes Project and simulated phenotypes. These data enabled evaluations of 
existing and newly developed statistical methods for rare variant sequence analysis for which 
standard statistical methods fail because of the rareness of the alleles. Various alternative 
approaches have been proposed that overcome the rareness problem by combining multiple rare 
variants within a gene. These approaches are termed collapsing methods, and our GAW17 group 
focused on studying the performance of existing and novel collapsing methods using rare 
variants. All tested methods performed similarly, as measured by type I error and power. Inflated 
type I error fractions were consistently observed and might be caused by gametic phase 
disequilibrium between causal and noncausal rare variants in this relatively small sample as well 
as by population stratification. Incorporating prior knowledge, such as appropriate covariates and 
information on functionality of SNPs, increased the power of detecting associated genes. 
Overall, collapsing rare variants can increase the power of identifying disease-associated genes. 
However, studying genetic associations of rare variants remains a challenging task that requires 
further development and improvement in data collection, management, analysis, and 
computation. 
 
Key words: 1000 Genomes Project, association, collapsing methods, next-generation sequencing 
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Introduction 
Genome-wide association studies have successfully identified hundreds of novel genetic 
loci associated with complex disease traits. In most cases, only a small portion of the heritability 
is explained by these associated common variants [Manolio et al., 2009; Eichler et al., 2010]. 
Although the summation of these associated loci may underestimate the total amount of 
heritability that common variants can explain [Yang et al., 2010], rare genetic variants might also 
contribute a sizable proportion of the genetic susceptibility to common diseases. In contrast to 
common variants associated with small effects, rare variants with putative functional change, 
such as nonsynonymous single-nucleotide polymorphisms (SNPs), are more likely to have a 
larger effect [Kryukov et al., 2007; Gorlov et al., 2008]. 
Current technology allows an exhaustive search for rare variants by sequencing the whole 
genome of a human being [Lee et al., 2010; Lupski et al., 2010; Sobreira et al., 2010]. Although 
the cost has drastically decreased in recent years, conducting a whole-genome sequencing project 
may not be cost-efficient for identifying functional rare variants associated with common 
diseases. The 30 million base pairs of the human exome account for about 1% of the whole 
human genome. With a fixed budget, an exome sequencing project can survey a much larger 
sample (required for detecting rare variants) with better coverage of the sequence reads (higher 
quality of the calls of rare variants). Several studies have demonstrated the utility of exome 
sequencing in identifying functional variants related to human diseases [Bilguvar et al., 2010; 
Gilissen et al., 2010; Ng et al., 2010a, 2010b; Walsh et al., 2010]. 
Because of the low allele frequencies, traditional regression-based methods do not work 
well with rare variants derived from sequencing data. To address the analytical challenge of 
identifying rare genetic variants associated with diseases, investigators have developed a number 
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of collapsing methods to summarize the individual rare variants in association analyses. These 
methods have been described in detail by Dering et al. [2011a]. Genetic Analysis Workshop 17 
(GAW17) provided exome sequencing data from the 1000 Genomes Project and simulated 
phenotypic traits, both binary and quantitative [Almasy et al., 2011]. These simulated data sets 
with a large number of rare variants can be used to evaluate the existing and newly proposed 
methods to identify the associations of rare variants. For exome sequencing data, a natural unit 
for collapsing genetic variants is the gene. Although many of these collapsing methods can be 
used for common variants, GAW17 Group 15 focused on the methods’ performance in 
identifying associations of rare variants, sometimes jointly with common variants.  
All 12 contributions to GAW17 Group 15 used the simulated data of 697 unrelated 
individuals. Taking advantage of 200 simulated data sets (simulated phenotypes with measured 
genotypes from the 1000 Genomes Project) of one binary trait and three quantitative traits and 
the available underlying genetic models, many contributors assessed type I error and power of 
existing and novel collapsing methods. These evaluations and comparisons help us to understand 
the performance of these methods in terms of both type I error and power.  
Several existing collapsing methods for rare variant analysis—collapsing and summation 
test (CAST), indicator coding test RVT2 (rare variant test 2), combined multivariate and 
collapsing (CMC) method, weighted-sum (WS) collapsing method, data-adaptive summation 
(aSUM), and variable threshold (VT) collapsing method—have been assessed by Group 15 
contributors. The CMC, WS, aSUM, and VT methods also provide flexible frameworks with 
which to analyze collapsed rare variants and common variants jointly. These methods have been 
summarized by Dering et al. [2011a]. Here, we describe novel approaches suggested and 
explored by Group 15 contributors.  
 5
 
Collapsing Methods for Rare Variant Analysis: Cumulative Minor Allele Test {AU: 
Because there is only one subhead, we can combine the main head and the subhead. This is 
standard practice for journals and books.} 
The cumulative minor allele test (CMAT) for rare variant analysis is derived from the 
chi-square statistic and compares the total number of rare variants present in the gene for case 
subjects and control subjects [Zawistowski et al., 2010]. For a sample with NA case subjects and 
NU control subjects, assume F > 1 variants in the region of interest (ROI), each with a weighting 
factor wj ≥ 0 (j = 1, …, F). The CMAT statistic compares the proportion of rare alleles in the 
case subjects to the proportions in the control subjects as follows:  
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are the weighted minor allele counts across all sites in the ROI for case and control subjects, 
respectively.  
Because the genetic variants may be in linkage disequilibrium and have small counts, a 
permutation strategy that shuffles the case-control labels and maintains the correlation structure 
of the genetic data is used to determine the statistical significance of the CMAT statistic. Luedtke 
et al. [2011] evaluated CMAT along with the CMC, WS, and RVT2 methods for their 
performance in analyzing the dichotomized trait. One thousand permutations were performed to 
determine the empirical p-value of each gene, that is, the ROI [Luedtke et al., 2011]. 
 
Genetic Similarity and Distance  
 An alternative approach to studying genetic associations is to investigate the relationship 
between pairs of individuals. This approach can be particularly useful for identifying clusters of 
individuals in the phenotype-genotype space. Methods based on correlating genotypic similarity 
and phenotypic similarity have been developed for genetic epidemiological research [Shannon et 
al., 2002; Beckmann et al., 2005]. In GAW17 Group 15, two pairwise approaches, one based on 
the kernel function and the other based on the Mantel test, were implemented and assessed using 
the GAW17 data.  
 
Kernel-Based Association Test 
 The kernel-based association test (KBAT) combines multiple genetic variants and 
reduces the degrees of freedom and was initially proposed to study the genetic association of 
common variants [Kwee et al., 2008]. KBAT extends the least-squares kernel machines for 
quantitative traits and the logistic kernel machine for dichotomized traits to study multivariable 
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associations [Kwee et al., 2008; Wu et al., 2010]. Li et al. [2011] implemented and investigated 
the KBAT because it is suitable for combining multiple rare variants within a ROI. For 
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for a given kernel function k(·, ·). {AU: In the preceding sentence, should the k in k(·, ·) be 
capitalized, i.e., K(·, ·), to match Eq. 5 and the subsequent text?} The kernel function K(Gik, Gjk) 
measures the genetic similarity between two individuals i and j at the SNPs in gene k. The 
estimates of β and α (equivalently, h) can be obtained by plugging h(G) into the penalized 
likelihood function.  
Li et al. [2011] implemented the kernel function based on genetic similarity measured by 
identity-by-state (IBS) sharing between two individuals i and j at the SNPs within gene k. To 
consider the potentially larger effect of the genetic variants with lower frequency, this flexible 
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where Mrik denotes the genotype of individual i at SNP r in gene k and wlk is a weight based on 




 Instead of directly testing the associations between rare variants or their collapsed 
summary statistics, Sun et al. [2011] implemented a collapsing method to examine the 
correlation between the genetic dissimilarity (i.e., the genetic distance) and phenotypic 
dissimilarity. This method is a Mantel-type statistic that tests the dependence between the 
elements of two matrices [Mantel, 1967]. The two matrices contain data from multiple variables 
obtained on a common sample of subjects, where the rows correspond to the subjects and the 
columns contain data on the two sets of variables X and Y. For n subjects with two variables X 
and Y, two distance matrices, each with n(n − 1)/2 pairwise distances, are first calculated. The 
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where n denotes the number of subjects in the distance matrices and Xij and Yij are the pairwise 
distances between subjects i and j. The elements of a distance matrix are not independent, and 
determination of the type I error level for the correlation (i.e., Mantel’s statistic Z) between two 
distance matrices is not straightforward. Therefore the significance level is usually evaluated 
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using a permutation procedure [Beckmann et al., 2005]. For a given gene, the genetic distance Xij 
between each pair of subjects is calculated as the sum of difference of the additive effect on each 
rare SNP. For a SNP, the distance between two homozygotes is 2, but the distance is 1 between 
homozygote and heterozygote genotypes. The genetic distance between a pair of subjects on the 
gene level is the sum of the genetic distance of individual SNPs. For a gene involving two SNPs 
with alleles A/a and B/b, the genetic distance between a pair of individuals ranges from 0 (same 
genotype) to 4 (AABB vs. aabb). The phenotypic distance is the absolute difference of the 
phenotypic value between a pair of individuals (|Yi − Yj|). 
 
Integrated Analysis of Both Rare and Common Variants 
As shown in several previous studies [Li and Leal, 2008; Madsen and Browning, 2009], 
combining rare and common variants within a ROI can improve the power of identifying a 
disease-associated region when both types of genetic variants contribute to the disease. Two 
Group 15 studies proposed alternative approaches to jointly analyzing rare and common variants 
by applying variable selection and the least absolute shrinkage and selection operator (LASSO) 
[Dasgupta et al., 2011]. 
 
Data-Adaptive Forward Selection  
Dai et al. [2011] proposed a three-step procedure that uses the associated common SNP 
as an anchor to select the rare variants. The variable selection procedure starts with selecting the 
most significant common SNP in the ROI. Then the rare SNPs that improve the goodness-of-fit 
are added to the model one at a time. The selection of rare SNPs repeats until no such rare SNP 
exists in the ROI. The goodness-of-fit is measured by the F statistic of a linear regression model 
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that combines the selected variants into a collapsing score. The final test statistic is the absolute 
value of the t statistics for the final linear regression model E(y) = α + βSfinal, where Sfinal is the 
final collapsed score including all selected common and rare variants. Without knowledge of the 
distribution of the final t statistic, a genome-wide permutation needs to be performed to evaluate 
the global empirical p-value. This data-adaptive forward selection procedure selectively chooses 
only variants that improve the joint association between the ROI and the disease trait.  
 
LASSO  
The LASSO is an efficient variable selection method for high-dimensional data analysis 
[Tibshirani, 1996]. Recently, the LASSO and its variants have been adapted to the analysis of 
high-dimensional genetic variants [Szymczak et al., 2009; Dasgupta et al., 2011]. Chen et al. 
[2011] applied LASSO regression to select common variants that should remain in the model. 
They performed a 10-fold cross-validation for estimating the shrinkage parameter (λ) for the 
LASSO. The common variants remaining in the model after LASSO selection and the covariates 
and rare variant score were then fitted in a multiple regression model. The joint genetic 
association of common and rare variants was tested using the partial F test. 
Table I summarizes the analyses of rare variants performed by GAW17 Group 15 
contributors. Both the quantitative traits and the dichotomized trait were analyzed. Because the 
contributors decided to be either blinded or unblinded to the simulation answers, the analytical 
strategies discussed during the GAW17 meetings were heterogeneous. However, all contributors 
chose to use similar analytical approaches in their final contributions. Given the causal genetic 
associations simulated in 200 replicates, all work groups evaluated the performance of existing 
or novel approaches by testing type I error fraction and power [Chen et al., 2011; Dai et al., 
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2011; Dering et al., 2011b; Luedtke et al., 2011; Sun et al., 2011] or receiver operating 
characteristic (ROC) curves with similar measurements [Li et al., 2011; Lin et al., 2011; Sung et 
al., 2011]. Because all causal SNPs were nonsynonymous in the simulation model, six out of 
nine work groups examined the performance of collapsing methods by including 
nonsynonymous SNPs only. Almost all contributors implemented permutation tests to determine 
the statistical significance resulting from the nonstandard distribution of the test statistics derived 
from the collapsing methods. The inclusion of covariates was also considered to assess its impact 
on the performance of these methods. 
 
Results 
After extensive investigations of the collapsing methods for rare variant analysis, we 
observed several common themes in our group. Although the power can be improved under 
specific scenarios, such as filtering nonsynonymous SNPs and inclusion of appropriate 
covariates, the overall performance of all tested methods was similarly poor. By adjusting for 
multiple testing of thousands of genes, all collapsing methods were underpowered to detect 
genes with causal rare variants in 697 unrelated samples except for a few top genes, such as 
FLT1 and KDR for the simulated quantitative trait Q1.  
We also observed surprisingly high type I error fractions for Q1 and Q2 across all tested 
methods. For Q4, which did not have any causal genetic variants simulated, the type I error 
fraction of the tested methods was not inflated. Two work groups in Group 15 further 
investigated the potential causes of the inflated type I error [Luedtke et al., 2011; Sung et al., 
2011] and identified hundreds of SNPs in gametic phase disequilibrium with the causal rare 
variants. Gametic phase disequilibrium, also called gametic disequilibrium, is the nonrandom 
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correlation between genetic loci. Here, we use the term to define such nonrandom correlation 
between loci that are located beyond a local haplotype block, sometimes on different 
chromosomes. In extreme cases, a noncausal SNP had identical genotypes as the causal SNP for 
all 697 individuals.  
Another potential cause of inflated type I error is population structure. Principal 
components analysis (PCA), which is used to adjust for population structure, reduces type I error 
[He et al., 2011; Luedtke et al., 2011], but the effectiveness of controlling the false positives is 
influenced by the MAF [He et al., 2011]. Specifically, PCA reduced false-positive fractions more 
effectively in common SNPs (MAF > 0.05) than in rare SNPs (MAF < 0.01). Unfortunately, 
although false-positive fractions were reduced, the power to detect true associations was also 
reduced by using PCA. 
Not surprisingly, we confirmed that the power for identifying associations of rare variants 
can be improved by including the appropriate prior knowledge. For instance, incorporating the 
correct covariates in the model increased both sensitivity and specificity [Lin et al., 2011]. In 
addition, the power to identify associated genes increased by selecting only the nonsynonymous 
SNPs for all collapsing methods, because all causal rare variants were nonsynonymous SNPs in 
the simulation model. Meanwhile, the synonymous-SNPs-only test served as a negative control 
for assessing the false-positive fraction. Given that all simulated effects of rare variants were 
deteriorating, the data-adaptive methods, such as the aSUM method, did not perform better than 
the non-data-adaptive methods. 
We also observed interesting features of some novel approaches. The forward selection 
method combining both common and rare variants achieved substantially higher power than 
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other methods, which considered either rare or common variants regardless of their associations 
with the outcome [Dai et al., 2011].  
 
Discussion 
Inflation of Type I Error 
Overall we found that collapsing methods had limited capability to identify most causal 
genes because of low power and high type I error fraction. Inflated type I error fractions were 
consistently observed for simulated traits using all collapsing methods. The expected type I error 
for Q4, which has no causal variants, suggested that the inflation was not due to the statistical 
methods. A large number of SNPs in noncausal genes were in gametic phase disequilibrium with 
causal SNPs simulated for Q1 and Q2 [Li et al., 2011; Luedtke et al., 2011; Sung et al., 2011]; 
that is, they were highly correlated with causal SNPs. These highly correlated or even identical 
genotypes may account for the large number of false-positive genes for Q1, Q2, and the affection 
status. Because the number of rare variants (especially the private mutations observed only once 
in the sample) was much larger than the sample size, it was more likely that causal and noncausal 
variants shared the same or similar genotype distributions. For the sample size of 697, at least 
two private mutations were on the same individual’s genome among every 698 rare variants with 
private mutations. These pairs of rare variants, which may include simulated causal variants, had 
perfect correlation. The spurious correlations among causal and noncausal rare variants could 
have been caused by gametic phase disequilibrium and population stratification [Luedtke et al., 
2011]. A further analysis showed a higher amount of gametic phase disequilibrium than random 
chance, which suggests potential genotyping errors from the exomic sequencing; however, no 
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information about genotype calling, cleaning, or other preprocessing steps were available for 
these data to allow us to further pinpoint the cause.  
 
Permutation and Computation 
 Because of the unknown distribution of the test statistics and because of potential 
correlation among genetic variants, the Group 15 contributors needed to use permutation to 
accurately determine the statistical significance for most collapsing methods of rare variant 
analysis. Permutation is a computationally expensive procedure that generates the null 
distribution of the test statistic by deconstructing the relationship between predictors and 
outcome repeatedly. Permutation of high-dimensional data requires a large amount of 
computational resources. To achieve a significant empirical p-value adjusted for multiple testing, 
investigators need hundreds of thousands of permutations to scan the human exome. In a 
simplified example, a Bonferroni-corrected p-value of 0.05 for 20,000 human genes requires at 
least 400,000 permutations (1/(0.05/20,000)). Although the total number of human genes is 
approximately fixed in the equation, other factors (e.g., a non-gene-based ROI) might increase 
the total number of permutations needed.  
Improvements in both software and hardware can address this computational challenge. 
Well-implemented algorithms can greatly speed up the computation of high-throughput data for 
genetic epidemiological studies [Schwarz et al., 2010]. A large number of permutations can also 
be easily parsed into smaller jobs to take advantage of parallel computing available in all high-
performance computing facilities and smaller scale computer clusters. The multicore design of 
the latest CPUs and graphic processing units (GPUs) combined with parallel programming 
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techniques will help genetic epidemiologists to address computational challenges in analyzing 
rare variants and sequencing data.  
On the other hand, genetic epidemiologists start to face another issue of data 
management: how to securely transfer, store, and back up the large amount of sequencing data 
(terabytes rather than gigabytes). A well-designed computation environment will be critical to 
conquer these technical bottlenecks for analyzing next-generation sequencing data. More 
important, like all new forms of data for genetic epidemiological studies, the next-generation 
sequencing data need to be carefully examined and cleaned. The issue of data quality cannot be 
overemphasized at the early stage of the analysis of next-generation sequencing data. The valid 
scientific findings have to rely on high-quality sequencing data that are likely to be more critical 
for studying rare variants.  
 
Real Data Analysis: The More We Know, the More We Know What We Don’t Know 
One of the biggest questions still unanswered after extensive studies of simulated data is 
how to best analyze the real data with many rare variants from sequencing projects. With limited 
simulation models, we are not able to evaluate all scenarios where these assumptions are 
violated. In practice, we do not know the location and effect of noncoding causal variants (e.g., 
cis-regulatory elements), the proportion of causal variants that change protein coding 
(nonsynonymous vs. synonymous SNPs), the weight of a genetic variant relative to the allele 
frequency, the direction of the genetic effects (deteriorating vs. protective), or the boundary of an 
ROI. In that regard, the data-adaptive approaches and methods that require minimal assumptions 
are more favorable. Several interesting directions should be considered or combined in the future 
analysis of rare variants. The aSUM statistic addresses the issue that causal variants may not 
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have effects all in one direction. Unfortunately, the GAW17 data simulated only deteriorating 
effects that do not allow a formal test to examine the benefit of this flexible approach. The 
weighted KBAT seems to be less sensitive to the assumption of lower MAF and larger effect 
size. It suffers less power loss than the WS method when this assumption is violated [Li et al., 
2011]. 
All Group 15 contributors chose the gene, a natural unit of the human genome, as the 
ROI for collapsing genetic variants. However, the ROI can also be based on nongenic regions, 
such as transcriptional regulatory regions, functional domains within a gene, or a set of related 
genes (e.g., a protein complex or a pathway) [Dering et al., 2011a; Tintle and Pugh, 2011]. The 
benefits of choosing alternative ROIs cannot be assessed using the GAW17 data because of the 
limitation of the simulation. In real data analysis, using an alternative collapsing unit may help to 
identify disease-related molecular mechanisms by enriching the genetic signal.  
 Sequencing data provide the ultimate resolution of the genetic variants in human DNA. 
With large populations sequenced, eventually we will be able to identify the causal genetic 
associations on the human genome. With the improvements in measurement, data processing, 
management, and methods of analysis, we will be able to further understand the genetic causes 
of complex diseases and develop strategies to deliver better prevention, diagnosis, and treatment 
to the public.   
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Table I. Overview of Group 15 contributions 
Contribution Phenotype Collapsing method Rare SNP MAF (%) SNP filter Type I error Power Permutation 
Chen et al. [2011] Q1, Q4 RVT, aSUM, CMC, LASSO 0.5, 1, 5 All Y Y Y 
Dai et al. [2011] Q1, Q2 Forward selection, CAST, WS, 
RVT 
1 All Y Y Y 
Dering et al. [2011b] Affected CAST, CMC, WS, RVT 1, 2, 3, 5, 7, 10 All, nsyn, syn Y Y Y 
He  et al. [2011] Q1 RVT, aSUM 1 nsyn Y Y Y 
Li et al. [2011] Q1, Q2, Q4, Affected CMC, WS, KBAT, Bayesian 
mixed-effects model 
5 nsyn, syn Y Y Y 
Lin et al. [2011] Q1, Q2, Q4, Affected VT, WS, RVT 1, 5 All Y Y Y 
Luedtke  et al. [2011] Affected CMC, WS, RVT, CMAT 5 All, nsyn Y Y Y 
Sun  et al. [2011] Q1, Q4, Affected Mantel test 5 All, nsyn Y Y Y 
Sung et al. [2011] Q1, Q2 RVT 5 All, nsyn Y Y N 
 
CAST, collapsing and summation test; CMC, combined multivariate and collapsing method; WS, weighted-sum method; aSUM, 
adaptive summation method; RVT, rare variant test; VT, variable threshold method; CMAT, cumulative minor allele test; KBAT, 
kernel-based association test; nsyn, nonsynonymous; syn, synonymous. 
